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ABSTRACT 
Objective: Urinary tract infection (UTI) is the most common serious infection during infancy, adult male and female, as well as at the time of 
pregnancy. UTI is also the most common nosocomial infection in many hospitals and accounts for approximately 35% of all hospital acquired 
infections. Hence the present study was aimed to screen the presence of multi-drug resistant bacterial pathogens among the urine samples collected 
from in and out patients of multi-speciality hospital.  
Methods: Standard microbiological laboratory protocols were followed and about 152 samples were processed and screened. Among them, 49 
reported positive for the presence of urinary bacterial pathogens.  
Results: Among 49 isolates, Escherichia coli registered its prevalence in about 44 samples followed by Klebsiella spp. (4) and Pseudomones spp. (1). 
The gender wise distribution was found to be more among female patients (42%) than male patients (24%). The age wise distribution of infection 
among male and female patients was also noticed. Further, the multi-drug resistance of the isolates was done by using 8 antibiotics.  
Conclusion: All the isolates exhibited the multiple antibiotic resistance and the isolates showed 27 different antibiotic resistance patterns. This 
confirms the prevalence of ESBL producers among the urinary pathogens. 
Keywords: Uropathogens, E. coli, ESBL, Hospital acquired infection. 
 
INTRODUCTION 
Urinary tract infection (UTI) is projected to be about 150 million 
incidences per annum worldwide [1]. More than 8 million patients 
with urinary tract infections visit urology or gynecology clinics per 
year in the United States [3]. UTIs develop by either ascending or 
descending bacterial invasion into the urinary tract. The most 
common mode of infection is the ascending pathway, where fecal 
flora gain access to the urinary tract via colonization of the urethra 
[2]. Descending infections are the result of hematogenous spread of 
bacteria from a primary source located elsewhere in the body and 
it’s rare. The lower urinary tract infection is known as a simple 
cystitis (Bladder infection) and the infection in the upper urinary 
tract or in kidney is known as pyelonephrites [16]. 
UTI is one of the most recurrent infectious diseases among hospital-
acquired group [8]. It also reported to occur by community acquired 
group. The major causal agents of urinary tract infections by 
bacterial pathogens were found to be Enterococcus faecalis, 
Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis, Serratia 
marcescens, and Pseudomonas aeruginosa [11]. 
Depending on whether the infection is occurring for the first time or a 
repeated event, the UTI is classified into two types, uncomplicated and 
complicated infections. Uncomplicated UTI occurs due to bacterial 
infection, most often by E. coli. Women are frequently affected by 
uncomplicated UTI than men [26]. Complicated infections, which 
occur in men and women of any age, are also caused by bacteria, but 
they tend to be more severe and more difficult to treat [22].  
In order to achieve a satisfactory therapeutic effect, it is suggested that 
local information regarding the antimicrobial resistance of frequent 
pathogens should be established as a reference for the selection of 
empirical antimicrobial therapy [10]. Higher multidrug resistance 
rates were found to be common among hospital acquired UTI 
pathogens [7]. β-lactam antimicrobial agents are among the most 
widely used antibiotics to treat those communities and hospital 
acquired infections [14].  
Few authors have studied the risk factors associated with the UTI 
due to ESBL-producing bacteria in hospitalized patients. Extended-
spectrum β-lactamases (ESBLs) are a group of β-lactamases 
enzymes belongs to group 2, produced by Gram negative 
Enterobacteriaceae [4]. Due to rapid emergence of ESBL producing 
uropathogens over the last decade, the antimicrobial susceptibility 
profile has changed dramatically [19, 28]. Hence, the aim of the 
present study was to determine the prevalence and antibiotic 
resistant patterns of ESBL-producing bacterial uropathogens 
isolated from urine sample of both in and out patients in multi-
specialty hospitals around Coimbatore.  
MATERIALS AND METHODS 
Isolation and identification of uropathogenic bacteria 
Collection of samples 
With prior ethical clearance from the hospitals for this study, a total 
of 152 urine samples from multi-specialty hospitals in and around 
Coimbatore were collected for the isolation of uropathogenic 
bacteria. One millilitre of the sample was inoculated in Luria Bertani 
(LB) broth and incubated at 37°C for overnight. After incubation for 
about 24 h, one loopful of the culture was streaked on selective agar 
medium. The selective agar medium those were used for the 
isolation of enteric pathogens is tabulated (Table 1). Further, the isolates 
were identified by Gram’s staining and series of biochemical tests. 
 
Table 1: Selective medium for isolation of pathogens 
Selective media Bacterial genera 
Eosine Methylene Blue agar (EMB) E. coli 
Mac Conkey Agar Klebsiella spp. 
Nutrient Agar (NA) Proteus spp. 
King’s B medium Pseudomonas spp. 
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Maintenance of uropathogens 
Nutrient agar slants were prepared in the test tubes and pure 
culture of the uropathogen grown on the selective medium were 
streaked on it. The tubes were incubated at 37oC for 24 h and 
refrigerated for preservation. The cultures inoculated on to the Luria 
Bertani broth tubes were used for further use. 
Antibiotic susceptibility testing 
Antibiotic sensitivity was tested for all the 49 isolates. The 
antibiotics that are commonly used for the infection control were 
selected for the present study. 
Test procedure 
Antibiotic sensitivity test was carried out by disc diffusion method. 
Muller Hinton agar (HiMedia, India) were prepared, sterilized and 
poured onto sterile petriplates. The medium was allowed to solidify. 
Pure cultures grown in nutrient broth for 6-8 h were swabbed over 
MHA using sterile cotton swabs. Using antibiotic disc dispenser, 
discs were placed on the agar surface with sufficient space so as to 
avoid overlapping of inhibition zones. After 30 min of pre-diffusion 
time, the plates were incubated at 37o
Multiple antibiotic resistance (MAR) index of an isolate is the 
number of antibiotics to which the test isolate displayed resistance 
divided by the total number of antibiotics to which the test organism 
has been evaluated for sensitivity. MAR index value higher than 0.2 
is considered that the isolate have originated from high risk source 
of contamination like human, commercial poultry farms, swine and 
dairy cattle where antibiotics are very often used. MAR index value 
less than or equal to 0.2 is considered that the isolate have 
originated from animals in which antibiotics are used very rarely or 
never used. 
C for 18-24 h. After the 
incubation period, the diameter of the inhibition zone was measured 
and compared with the interpretative chart provided by the 
manufacturer and classified as resistant, intermediate and sensitive. 
Multiple antibiotic resistance index 
RESULTS 
Isolation and identification of uropathogenic bacteria 
The urine samples were collected from in and out patient in 
multispecialty hospitals around Coimbatore from both genders 
irrespective of age group. Among 152 samples, 133 samples were 
from in patients and 19 from out patients. The isolates were 
subjected to gram’s staining and streaked on to selective medium. As 
none of the isolates were found to be gram positive, the screening of 
gram positive bacteria on selective medium was neglected. A total of 
44 isolates exhibited metallic sheen colonies on to EMB agar plates 
which confirms the presence of E. coli in the samples, 4 isolates 
showed pink colour colonies on Mac Conkey agar confirms the 
presence of Klebsiella spp. And one isolate which produced 
pyocyanin was further confirmed the King’s B medium confirms the 
presence of Pseudomonas spp. None of the isolates exhibited 
swarming motility on the nutrient agar plates, which shows the 
absence of Proteus spp. Among the samples (Table 2). The isolates 
obtained from selective medium were further confirmed based on 
their biochemical profile. The typical biochemical profile of E. coli, 
Klebsiella spp. And Pseudomonas spp. Were tabulated (Table 3). 
 
Table 2: Percentage of uropathogenic bacteria 




1. 16 28 E. coli 44 29% 
2. 2 2 Klebsiella spp. 4 3% 
3. 1 - Pseudomonas spp. 1 0.7% 
 
Table 3: Typical biochemical profile of E. coli, Klebsiella spp. And Pseudomonas spp 
Gram’s 
staining 
Indole MR VP Urease TSI Catalase Glucose Lactose Maltose Sucrose motility Oxidase Suspected 
organism 
G-ve Rod - - + - + + - + - - + - E. coli 
G-ve Rod - + - + + + + + + + - - Klebsiella sp. 
G-ve Rod - - - + + + + - + + + + Pseudomonas 
sp. 
(-) Negative (+) Positive 
 
Table 4: Demograhic data of UTI among patients 
Category No. of samples Male Female No. of Positive samples Percentage 
% 
IP 133 73 60 40 30% 
OP 19 8 11 9 47% 
 
Table 5: Gender wise distribution of uropathogenic bacteria in UTI samples 
Gender Total no. of samples No. of Positive samples Percentage % 
Male 81 19 24% 
Female 71 30 42% 
 
Prevalence of uropathogenic bacteria  
The percentages of prevalence of uropathogenic isolates were 
screened. The prevalence was found to be high among out patients 
(47%) whereas 30% of incidence was noticed among the in patients 
(Table 4). The gender wise incidence was noticed among the 
patients.  
The highest percentage was noticed among female patients (42%) 
than male patients (24%), the results are tabulated (Table 5). The 
age wise prevalence of the pathogens had also registered. The 
highest prevalence of the UTI was found among the age of 60-69 
years of male patients (33%) and 100% of samples from female 
patients of the age 40-79 showed positive for the presence of 
bacterial pathogens. 
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Antibiogram of the isolates 
All the 49 isolates obtained were screened for the antibiotic 
sensitivity against 8 commercially available antibiotics. The highest 
percentage (100%) of resistance was found against cefotoxime and 
ceftazidime and least percentage of resistance was found against 
amikacin (14%). About 98% of isolates showed resistance against 
cefazolin and cefixime, 96% resistance towards vancomycin, 88% 
against nalidixic acid and 43% towards gentamicin, respectively. 
The isolates exhibited about 27 different antibiotic resistance 
patterns against 8 antibiotics used in this study. Klebsiella spp. and 
Pseudomona spp. shares the same antibiotic resistance pattern 
shown by E. coli. This shows that these organisms acquiesced the 
resistance through transferable elements like ‘R’ plasmids as these 
were closely related in their phylogeny. 
Multiple antibiotic resistance index 
The MAR index value of all the isolates ranged from 0.5 to 1. MAR 
index of 0.91 to 1 and 0.80 to 0.89 was exhibited by 0.04% and 55% 
of the isolates. MAR index of 0.70 to 0.79 and 0.60 to 0.69 was 
exhibited by 35% and 0.04% of the isolates respectively. About, 
0.02% isolates exhibited a MAR index value of 0.50 to 0.59. None of 
the isolates exhibited MAR index less than 0.5. The results serves as 
an evident that all the isolates were procured from the area were 
antibiotics are intensively used.  
DISCUSSION 
Various bacterial pathogens were reported to be involved in UTI. Many 
reporters had marked their conclusion that E. coli and Klebsiella spp. 
were found to be predominant in causing the UTI among both 
hospital-acquired and community-acquired patients. There are many 
evidences that these pathogens harbour resistance towards multiple 
antibiotics by producing varying β-lactamases. Hence the present 
study was conducted to screen the epidemiology of various bacterial 
pathogens in the UTI and to determine their antibiotic resistance. 
Tankhiwale et al. [29] screened a total 217 uropathogens and found 
that E. coli (49.8%) was the most common organisms followed by 
Klebsiella pneumoniae (37.8%), Pseudomonas aeruginosa (6.5%). 
This report strongly supports the present study, as E. coli (29%) was 
found to be more prevail among the patients irrespective of sex and 
gender followed by Klebsiella spp. (3%) and 0.7% of Pseudomonas 
spp. This result also strongly coincides with Jain et al. [12]. 
A large spectrum of organisms has been reported by Jain et al. [13] 
from patients of UTI with E. coli (65.95 %) and Klebsiella spp. (12.41 
%) being the most common in their study. Hasan et al. [9] has 
reported a high incidence of E. coli (50.7%) followed by Klebsiella 
spp. (27.6%) in 2436 uropathogens from patients with UTI.  
It is stated that UTI is predominantly a disease of the females due to 
a short urethra and proximity to the anal opening. The present study 
also marks its concordance for the early reports as the UTI 
prevalence was found to be more among female (42%) whereas, in 
male it’s about 24%. In a study, female preponderance for this 
infection was noted by Jain et al. [13]. They had also reported that 
the E. coli and Klebsiella spp. Were found to be the common isolates 
in females. This gives the strong evidence for the present study 
since, Pseudomonas spp. Was found only from male patient.  
Jain et al. [12] found that 17.3% in females patients with UTI 
whereas 13.3% in males. In coherence with prior studies, a higher 
prevalence of UTI among female was noted owing to the presence of 
anatomical and physical factors showing their increased 
vulnerability towards UTI was confirmed. The occurrence of UTI 
predominantly in patients with age ranging between 18-60 years in 
our study is similar to the findings of studies done in Kuwait and 
Nigeria [6, 23]. Women in the age group 16-45 years are most likely 
to suffer from UTI. Among the elderly, after 45 years males became 
more prone to UTI. The number of male patients increased 
significantly in the age group 46 years as prostatic gland 
enlargement and decrease of bacteriostatic prostatic secretions 
might account for such infections [30]. But in the present study 
evident for the occurrence was high at the age 40-49 among males 
and 40-79 among females. 
As other several reports, our study has also revealed that E. coli is 
the most predominant pathogen causing UTI in both sexes. On 
contrary to the findings of various other previous studies which 
documented Staphylococcus spp. as the second most common 
isolates [18,21], our results showed Klebsiella spp. Which is in 
concurrence with the findings of various authors [1,17,27].  
Resistance to several antimicrobial agents was prevalent among the 
isolates recovered not alone from the hospital and also found in 
environmental sources. These reports were noticed in many of the 
research works done world-wide. ESBL-producing 
Enterobacteriaceae is now evident in the community, especially 
among adults and is no longer confined only to the healthcare 
environment. Qi et al. [24] described an increase of over 10-fold in 
the community acquired ESBL E. coli incidence among the general 
population in Chicago, Illinois over a period of only 5 years while 
screening for urinary pathogens. In the current study, the incidence 
of uropathogen was noticed high among out patients (47%) than in 
patients (30%). This might be resulted due to age factor and risk of 
exposure of a patient. 
In the 1970s, multidrug resistance was practically nonexistent and 
the cause was restricted to mutation of chromosomal genes. 
However, during the last two decades bacterial resistance mediated 
by plasmids, which carry resistant gene to a large number of 
antibiotics, which are rapidly transferred, has worsened the scenario 
[25]. Due to high levels of resistance found to first choice drugs, it is 
important to know the resistance aspects of the pathogens in order 
to help in use of appropriate therapy or else, the empirical therapy 
became a difficult clinical decision. 
In the present study, all most all the isolates showed multidrug 
resistance. The least percentage of resistance (7%) was noticed 
against amikacin. Klebsiella spp. and Pseudomonas spp. Were found 
to be sensitive towards amikacin. Only E. coli was found to be 
resistant to amikacin. This result coincides with the result of Khan et 
al. [15] who recorded 7.1% of E. coli was resistant against amikacin. 
About 98% of isolates showed resistance against cefazolin in the 
present study. Moraes et al. [20] reported that 99% of E. coli was 
found to be resistant towards cefazolin. But Wu et al. [31] reported 
that cefazolin can be used as an alternate drug for treating urinary 
pathogens. This difference in susceptibility might be resulted due to 
non-exposure of the test isolates used by Wu and their co-workers. 
The resistance against cefixime and cefotoxime was found to be 
90%, 84.3%, 80% and 84.3% according to the reports of Jain et al. 
[13] and Noor et al. [30], whereas in the current study it was noticed 
as 98% and 100%. Jain et al. [12] reported that 57% of isolates were 
found to be resistance towards gentamicin. Dayan et al. [5] recorded 
50% of resistance towards gentamycin. The result of the current 
study also more or less coincides with the early reports since, the 
resistance against gentamicin was found to be 43% in our study.  
About 100% of isolates showed resistance towards ceftazidime in 
the present study, Jain et al. [13] noticed 82% of resistance. Against 
nalidixic acid and vancomycin, the test isolates showed 88% and 
96% of resistance. This strongly coincides with the report of Jain et 
al. [13] and Noor et al. [30] as they reported that their 94% and 
82.9% of test isolates showed resistance towards nalidixic acid. In 
contray, Jain et al. [12] has reported only 12% of their test isolates 
were resistant to vancomycin. These variations in the antibiotic 
resistance may occur due to the frequency of usage of particular 
antibiotics. 
CONCLUSION 
From the present study, we can conclude that E. coli was found to be 
most predominant bacterial uropathogen in UTI cases of the study 
area. The results of our study give brief information about the 
multidrug resistance, and also the prevalence of ESBL producing 
bacteria among the patients reported having community acquired 
UTI. Further, we also conclude that amikacin can be used in the 
empirical antibiotic therapy for achieving the better treatment.  
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